Ginkgo Bioworks Holdings (DNABW) Equity Income (2020 - 2023)

Ginkgo Bioworks Holdings has reported Equity Income for 4 years, with the latest figure at -$1.1 million in Q4 2023.

• For the quarter ending Q4 2023, Equity Income fell 111.19% year-over-year to -$1.1 million; the trailing twelve-month figure through Sep 2024 stood at -$1.1 million (down 113.18% YoY), and the FY2023 full-year result was -$2.6 million, up 93.98% from the prior year.
• Equity Income for Q4 2023 stood at -$1.1 million, down from -$67000.0 in the prior quarter.
• The five-year high for Equity Income was $59.9 million in Q4 2021, with the low at -$39.7 million in Q3 2021.
• Historically, Equity Income has averaged -$5.1 million across 4 years, with a median of -$4.3 million in 2021.
• The largest YoY upside for Equity Income was 368.11% in 2021 against a maximum downside of 16630.38% in 2021.
• Ginkgo Bioworks Holdings' Equity Income stood at -$22.3 million in 2020, then jumped by 368.11% to $59.9 million in 2021, then plunged by 83.31% to $10.0 million in 2022, then sank by 111.19% to -$1.1 million in 2023.
• The last three Equity Income figures came in at -$1.1 million (Q4 2023), -$67000.0 (Q2 2023), and -$1.4 million (Q1 2023), per Business Quant data.